ClinConnect ClinConnect Logo
Search / Trial NCT04270045

Forced Oscillometry in Infants with Bronchopulmonary Dysplasia

Launched by WINSTON MANIMTIM · Feb 12, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a method called forced oscillometry (FOT) to better understand how the lungs work in infants with a condition known as bronchopulmonary dysplasia (BPD). BPD often affects premature babies and can lead to breathing difficulties. The researchers want to see how well this technique can measure lung function in both premature infants with BPD and term infants who do not have any lung issues.

If you have a premature baby with BPD who is breathing room air or receiving a small amount of oxygen but can breathe without assistance for short periods, they might be eligible to participate in this study. Additionally, healthy infants older than 36 weeks who are less than 4 weeks old may also join. During the trial, participants will undergo non-invasive tests to check their lung function, which means there won't be any uncomfortable procedures involved. This study is currently looking for participants, and it aims to help improve the understanding and treatment of breathing problems in infants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Preterm Cohort:
  • Premature infants with BPD who are in room air based on the (per NICHD definition)
  • Premature infants with BPD who are receiving low flow O2 support and able to maintain normal spO2 in Room air for brief period ( up to 3 minutes) Term Cohort without pulmonary disease
  • Infants \>36 weeks gestational age without pulmonary disease
  • Infants \< 4 weeks of age
  • Outpatient Cohort:
  • Former preterm infants \< 32 weeks at birth
  • Those with BPD based on NIH 2001 definition
  • Seen prior to 2 years of age
  • Exclusion Criteria:
  • Infants with BPD requiring invasive or non-invasive positive pressure ventilation
  • Infants with BPD who have associated genetic diagnosis or major congenital anomalies.

About Winston Manimtim

Winston Manimtim is a dedicated clinical trial sponsor with a focus on advancing innovative therapies to improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the organization collaborates with leading research institutions and healthcare professionals to conduct meticulously designed clinical studies. Winston Manimtim prioritizes patient safety and data integrity, ensuring that each trial is aligned with regulatory requirements and best practices in clinical research. Through its strategic initiatives, the sponsor aims to accelerate the development of groundbreaking treatments across various therapeutic areas, ultimately contributing to the advancement of medical science and patient care.

Locations

Kansas City, Missouri, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials